STOCK TITAN
  1. Home
  2. Sec-filings
  3. CI
  4. [Form 4] Cigna Group Insider Trading Activity

Cigna CEO reports Form 4 purchase: 4,134 shares at $241.8762

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

The Cigna Group (CI) Chairman & CEO and director reported an open‑market purchase of 4,134 shares on 11/03/2025 at a weighted average price of $241.8762, with individual prices ranging from $241.876 to $241.97.

Following the transaction, beneficial ownership stands at 21,356 shares held directly; 157,935 shares held indirectly by trust; 440,798 shares held indirectly by a grantor retained annuity trust; and 1,782.7866 shares held indirectly via the 401(k) plan.

Positive

  • None.

Negative

  • None.
Insider Cordani David
Role Chairman & CEO
Bought 4,134 shs ($1000K)
Type Security Shares Price Value
Purchase Common Stock, $.01 Par Value 4,134 $241.8762 $1000K
holding Common Stock, $.01 Par Value -- -- --
holding Common Stock, $.01 Par Value -- -- --
holding Common Stock, $.01 Par Value -- -- --
Holdings After Transaction: Common Stock, $.01 Par Value — 157,935 shares (Indirect, By Trust); Common Stock, $.01 Par Value — 21,356 shares (Direct)
Footnotes (1)
  1. Represents the weighted average price of the shares purchased. The prices actually paid ranged from $241.876 to $241.97 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range. Reflects the transfer by the Reporting Person's grantor retained annuity trust of 165,575 shares of common stock on June 9, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person of 271,986 shares of common stock on August 4, 2025 to the Reporting Person's grantor retained annuity trust. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cordani David
(Last) (First) (Middle)
900 COTTAGE GROVE ROAD
(Street)
BLOOMFIELD CT 06002
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman & CEO
3. Date of Earliest Transaction (Month/Day/Year)
11/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 Par Value 11/03/2025 P 4,134 A $241.8762(1) 157,935 I By Trust
Common Stock, $.01 Par Value 21,356(2) D
Common Stock, $.01 Par Value 440,798(2) I By GRAT
Common Stock, $.01 Par Value 1,782.7866(3) I By 401(k)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the weighted average price of the shares purchased. The prices actually paid ranged from $241.876 to $241.97 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares purchased at each price within the range.
2. Reflects the transfer by the Reporting Person's grantor retained annuity trust of 165,575 shares of common stock on June 9, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person of 271,986 shares of common stock on August 4, 2025 to the Reporting Person's grantor retained annuity trust.
3. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
Remarks:
Tyler Gratton, attorney-in-fact 11/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Cigna (CI) disclose in this Form 4?

The Chairman & CEO and director purchased 4,134 shares on 11/03/2025 at a $241.8762 weighted average price.

What price range did the CI insider pay?

The shares were bought within a range of $241.876 to $241.97 per share.

How many CI shares does the insider own after the trade?

Post-transaction holdings are 21,356 direct; 157,935 indirect by trust; 440,798 indirect by GRAT; and 1,782.7866 via the 401(k) plan.

What does transaction code 'P' mean on the CI Form 4?

Code P indicates an open‑market or private purchase of non-derivative securities.

What roles does the reporting person hold at Cigna (CI)?

The reporting person is a Director and Officer (Chairman & CEO).

Is any part of the CI ownership indirect?

Yes. Indirect holdings include 157,935 shares by trust, 440,798 shares by GRAT, and 1,782.7866 shares via the 401(k).